Effective treatment of cervical dystonia with botulinum toxin: review

被引:3
作者
Kedlaya, D
Reynolds, LW
Strum, SR
Waldman, SD
机构
[1] Loma Linda Univ, Sch Med, Ctr Pain Management, Loma Linda, CA 92354 USA
[2] Loma Linda Univ, Sch Med, Dept Phys Med & Rehabil, Loma Linda, CA 92350 USA
[3] Univ Missouri, Kansas City Sch Med, Kansas City, MO USA
关键词
cervical dystonia; torticollis; botulinum toxin; treatment; complications;
D O I
10.3233/BMR-1999-13102
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Cervical dystonia is the most common form of focal dystonia in adults. It is characterized by involuntary contraction of neck muscles, causing abnormal posture and movements of the head. Pain is present in about 75% of patients and usually considered the major cause of disability in these patients. Botulinum toxin injection into the dystonic neck muscles is considered the treatment of choice for patients with cervical dystonia. Botulinum toxin binds presynaptically to cholinergic nerve terminals causing decreased release of acetyl choline and reduction in muscle tone. It is important to precisely identify the sites of pain and the muscles responsible for the abnormal posture to have better success. The incidence of complications can be reduced by the proper choice of dose for specific muscles. In this article, the authors review the clinical features, course, and pathophysiology of cervical dystonia. Also reviewed are the chemistry, pharmacology, mechanism of action of botulinum toxin along with practical aspects of its use and complications associated with its use in the treatment of cervical dystonia.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 54 条
[1]  
*AAN, 1990, NEUROLOGY, V40, P1332
[2]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[3]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29
[4]   BOTULINUM A TOXIN FOR THE TREATMENT OF SPASMODIC TORTICOLLIS - DYSPHAGIA AND REGIONAL TOXIN SPREAD [J].
BORODIC, GE ;
JOSEPH, M ;
FAY, L ;
COZZOLINO, D ;
FERRANTE, RJ .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1990, 12 (05) :392-399
[5]   BOTULINUM TOXIN IN CERVICAL DYSTONIA - LOW-DOSAGE WITH ELECTROMYOGRAPHIC GUIDANCE [J].
BRANS, JWM ;
DEBOER, IP ;
ARAMIDEH, M ;
DEVISSER, BWO ;
SPEELMAN, JD .
JOURNAL OF NEUROLOGY, 1995, 242 (08) :529-534
[6]   Botulinum toxin versus trihexyphenidyl in cervical dystoni - A prospective, randomized, double-blind controlled trial [J].
Brans, JWM ;
Lindeboom, R ;
Snoek, JW ;
Zwarts, MJ ;
vanWeerden, TW ;
Brunt, ERP ;
vanHilten, JJ ;
vanderKamp, W ;
Prins, MH ;
Speelman, JD .
NEUROLOGY, 1996, 46 (04) :1066-1072
[7]   Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia [J].
Brans, JWM ;
Lindeboom, R ;
Aramideh, M ;
Speelman, JD .
NEUROLOGY, 1998, 50 (05) :1461-1463
[8]  
BRIN MF, 1997, MUSCLE NERVE S6, V20, pS146
[9]   THE ACTION OF BOTULINUM TOXIN ON THE NEURO-MUSCULAR JUNCTION [J].
BURGEN, ASV ;
DICKENS, F ;
ZATMAN, LJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1949, 109 (1-2) :10-24
[10]   IDIOPATHIC CERVICAL DYSTONIA - CLINICAL CHARACTERISTICS [J].
CHAN, J ;
BRIN, MF ;
FAHN, S .
MOVEMENT DISORDERS, 1991, 6 (02) :119-126